Clinical Trial Results: Positive outcomes often lead to price increases, while negative results can cause significant drops.

Regulatory Approvals: FDA approval of Pfizer products typically boosts stock value, whereas rejection can negatively impact it.

Competition: New drugs from competitors can affect Pfizer's market share and, consequently, its stock price.

Mergers & Acquisitions: Announcements of mergers or acquisitions by Pfizer or its competitors can influence investor sentiment and stock valuation.

Overall Market Conditions: Broad economic trends and investor sentiment in the stock market can generally impact all stocks including Pfizer's.

Financial Performance: Quarterly and annual earnings reports showing revenue growth and profitability are crucial drivers of stock price appreciation.

Patent Expiration: Loss of exclusivity on key drugs due to patent expiry can significantly reduce revenue and impact stock value.

Government Regulations: Changes in healthcare policies and drug pricing regulations can affect Pfizer's profitability and investor confidence.

Public Perception: News and media coverage impacting public trust in Pfizer can influence stock performance.

Dividend Policy: Changes to Pfizer's dividend payout ratio or dividend yield can attract or deter investors, impacting stock price.

Analyst Ratings: Upgrades or downgrades from financial analysts can influence investor behavior and affect stock prices.